Loading articles...
Peptide Therapies: Decoding Evidence from Topicals to Longevity
Peptide therapies show varied efficacy across indications, from established dermatological uses to investigational longevity applications. Clinicians must scrutinise the evidence for each specific peptide.
26 States Sue to Block Medicaid Work Requirements, Citing Access Concerns
A coalition of 26 states filed suit to prevent the implementation of Medicaid work requirements, arguing the policy jeopardizes healthcare access for vulnerable populations.
Obamacare Enrollment Shrinks in Many States, Federal Data Shows
New federal data reveals a significant decrease in Obamacare enrollment across numerous states over the past year, impacting access to health coverage.
ACA Insurers Seek Higher Premiums Amid Enrollment Decline
Affordable Care Act insurers are requesting substantial premium increases for 2025, citing a decline in enrollment and rising healthcare costs.
Leapfrog Group's Legal Defeat Underscores Hospital Quality Rating Challenges
A recent court ruling against the Leapfrog Group highlights the significant hurdles in accurately and fairly rating hospital quality, raising questions about current methodologies.
Dana-Farber CEO Details Split from Mass General Brigham, New Hospital Plans
Dana-Farber Cancer Institute CEO Laurie Glimcher outlined plans for an independent future, including a new cancer hospital, following its separation from Mass General Brigham.
Judge Temporarily Blocks Subpoenas in NY Transgender Care Probe
A New York judge temporarily blocked subpoenas seeking patient records in a criminal probe of transgender care at two hospitals, citing patient privacy concerns.
NIH diversity programs doubled PhD odds for undergraduates, 20-year study finds
NIH-funded diversity programs significantly increased the likelihood of undergraduates earning a PhD, doubling their odds over two decades.
Next-Gen CRISPR Improves Embryo Editing Accuracy, Stoking Ethical Debate
Advanced CRISPR tools enhance precision in human embryo gene editing, reducing off-target effects but intensifying ethical concerns over germline modification.